| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
*
Division of Cardiovascular Research, St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA 02135;
Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan; and
Program in Cell, Molecular, and Developmental Biology, Sackler School of Biomedical Sciences, Tufts University, Boston, MA 02111
Despite recent advances in immunosuppressive therapy, accelerated coronary atherosclerosis remains a major problem in the long-term survival of transplant recipients. Chronic graft vasculopathy is believed to result from recipient inflammatory responses, and it is characterized by early mononuclear cell infiltration of the transplanted vessel. Here we show that endothelial cells can be genetically modified to overexpress functional, cell-surface Fas ligand (FasL) by adenovirus-mediated gene transfer without undergoing self-destruction. In a rodent model of transplant graft vasculopathy, endothelial overexpression of FasL attenuated T cell and macrophage infiltration at 1 wk posttransplantation. These vessels also displayed reduced neointima formation at one and 2 mo posttransplantation. These results indicate that inhibition of the early inflammatory response to allografted vessels by endothelial cell-specific overexpression of FasL may have utility in the treatment of transplant arteriosclerosis.
This article has been cited by other articles:
|
|
 |
|
  M. M. Kavurma, N. Y. Tan, and M. R. Bennett Death Receptors and Their Ligands in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., October 1, 2008; 28(10): 1694 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Q. Nhan, W. C. Liles, and S. M. Schwartz Role of Caspases in Death and Survival of the Plaque Macrophage Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 895 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Bohana-Kashtan and C. I. Civin Fas Ligand as a Tool for Immunosuppression and Generation of Immune Tolerance Stem Cells, November 1, 2004; 22(6): 908 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yang, K. Sato, T. Aprahamian, N. J. Brown, J. Hutcheson, A. Bialik, H. Perlman, and K. Walsh Endothelial Overexpression of Fas Ligand Decreases Atherosclerosis in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1466 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Luo, A. Liu, Y. Chen, H. M. Lim, J. Marshall-Neff, J. H. Black, W. Baldwin III, R. H. Hruban, S. C. Stevenson, P. Mouton, et al. Inhibition of Accelerated Graft Arteriosclerosis by Gene Transfer of Soluble Fibroblast Growth Factor Receptor-1 in Rat Aortic Transplants Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1081 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Duan, Z. Zhou, S.-F. Jia, M. Colvin, E. A. Lafleur, and E. S. Kleinerman Interleukin-12 Enhances the Sensitivity of Human Osteosarcoma Cells to 4-Hydroperoxycyclophosphamide by a Mechanism Involving the Fas/Fas-Ligand Pathway Clin. Cancer Res., January 15, 2004; 10(2): 777 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Young, L. S. Kay, M. J. Phillips, and L. Zhang Antitumor Activity Mediated by Double-Negative T Cells Cancer Res., November 15, 2003; 63(22): 8014 - 8021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Losordo, J. M. Isner, and L. J. Diaz-Sandoval Endothelial Recovery: The Next Target in Restenosis Prevention Circulation, June 3, 2003; 107(21): 2635 - 2637. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yang, S. P. Jones, T. Suhara, J. J. M. Greer, P. D. Ware, N. P. Nguyen, H. Perlman, D. P. Nelson, D. J. Lefer, and K. Walsh Endothelial Cell Overexpression of Fas Ligand Attenuates Ischemia-Reperfusion Injury in the Heart J. Biol. Chem., April 18, 2003; 278(17): 15185 - 15191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Askenasy, E. S. Yolcu, Z. Wang, and H. Shirwan Display of Fas Ligand Protein on Cardiac Vasculature as a Novel Means of Regulating Allograft Rejection Circulation, March 25, 2003; 107(11): 1525 - 1531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Buonocore, F. Paulart, A. Le Moine, M. Braun, I. Salmon, S. Van Meirvenne, K. Thielemans, M. Goldman, and V. Flamand Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T-cell responses in vivo Blood, February 15, 2003; 101(4): 1469 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Li, M. S. Kluger, L. A. Madge, L. Zheng, A. L. M. Bothwell, and J. S. Pober Interferon-{gamma} Augments CD95(APO-1/Fas) and Pro-Caspase-8 Expression and Sensitizes Human Vascular Endothelial Cells to CD95-Mediated Apoptosis Am. J. Pathol., October 1, 2002; 161(4): 1485 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wang, C. Dong, S. C. Stevenson, E. E. Herderick, J. Marshall-Neff, S. S. Vasudevan, N. I. Moldovan, R. E. Michler, N. R. Movva, and P. J. Goldschmidt-Clermont Overexpression of Soluble Fas Attenuates Transplant Arteriosclerosis in Rat Aortic Allografts Circulation, September 17, 2002; 106(12): 1536 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zhu, L. Luo, Y. Chen, D. W. Paty, and M. S. Cynader Intrathecal Fas Ligand Infusion Strengthens Immunoprivilege of Central Nervous System and Suppresses Experimental Autoimmune Encephalomyelitis J. Immunol., August 1, 2002; 169(3): 1561 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Janin, C. Deschaumes, M. Daneshpouy, J. Estaquier, J. Micic-Polianski, P. Rajagopalan-Levasseur, K. Akarid, N. Mounier, E. Gluckman, G. Socie, et al. CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications Blood, April 15, 2002; 99(8): 2940 - 2947. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
